Biocryst Pharmaceuticals (BCRX) Revenue (2010 - 2026)
Biocryst Pharmaceuticals' Revenue came in at $218.25 million for Q2 2026, up 33.6% from $163.35 million a year earlier and up 39.5% from the prior quarter.
Powered by 
Analysis
Biocryst Pharmaceuticals (BCRX) Revenue (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Biocryst Pharmaceuticals reported Revenue of $940.61 million, up 68.7% year-over-year; for FY2025, it came in at $874.84 million, up 94.1% from FY2024.
- Revenue has increased in each of the last five years, with a five-year compound annual growth rate of 117.9% (FY2020 to FY2025).
- Going back by year, Revenue was $450.71 million in FY2024 (+36.0%), $331.41 million in FY2023 (+22.4%), $270.83 million in FY2022 (+72.3%) and $157.17 million in FY2021 (+782.4%).
- The five-year range for quarterly Revenue is $40.99 million (Q3 2021) to $406.56 million (Q4 2025).
- Year-over-year, Revenue has increased for 18 consecutive quarters, with growth averaging 58.6% over the last eight quarters.
- Across the past five years, year-over-year growth in Revenue ran from 7.5% in Q1 2026 to 571.8% in Q3 2021.
- Business Quant data shows BCRX's Revenue at $156.41 million (Q1 2026), $406.56 million (Q4 2025) and $159.4 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 3.33 Bn |
| 10 | Biocryst Pharmaceuticals | 2.11 Bn | 1.03 Bn | 214.41 Mn | 218.25 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 218.25 Mn |
| Mar 31, 2026 | 156.41 Mn |
| Dec 31, 2025 | 406.56 Mn |
| Sep 30, 2025 | 159.40 Mn |
| Jun 30, 2025 | 163.35 Mn |
| Mar 31, 2025 | 145.53 Mn |
| Dec 31, 2024 | 131.53 Mn |
| Sep 30, 2024 | 117.09 Mn |
| Jun 30, 2024 | 109.33 Mn |
| Mar 31, 2024 | 92.76 Mn |
| Dec 31, 2023 | 93.40 Mn |
| Sep 30, 2023 | 86.74 Mn |
| Jun 30, 2023 | 82.49 Mn |
| Mar 31, 2023 | 68.78 Mn |
| Dec 31, 2022 | 79.55 Mn |
| Sep 30, 2022 | 75.83 Mn |
| Jun 30, 2022 | 65.53 Mn |
| Mar 31, 2022 | 49.92 Mn |
| Dec 31, 2021 | 47.16 Mn |
| Sep 30, 2021 | 40.99 Mn |
API Access
Biocryst Pharmaceuticals Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=BCRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "BCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=BCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();